期刊文献+

早期干预钙磷代谢对慢性肾脏病左室肥厚的影响 被引量:2

Influence of early intervention in calcium and phosphorus metabolism in chronic kidney disease left ventricular hypertrophy
原文传递
导出
摘要 目的 探讨早期干预钙磷代谢对改善慢性肾脏病患者左室肥厚的影响.方法 将住院治疗的116例非透析慢性肾脏病3、4期患者随机分为干预组和对照组,对干预组患者进行早期钙磷代谢干预,观察两组患者的血钙、血磷和左室心肌质量指数的变化情况.结果 干预组患者干预后的血磷、钙磷乘积、血全段甲状旁腺素均显著低于对照组,差异有统计学意义(P<0.05);干预组的LVMI显著低于干预前,也显著低于对照组,差异有统计学意义(P<0.05).结论 对慢性肾脏病患者进行早期钙磷代谢干预能有效改善患者的左室肥厚症状,有利于患者整个病情的改善. Objective To investigate the early intervention to improve calcium and phosphorus metabolism in chronic kidney disease patients left ventricular hypertrophy. Methods 116 cases of non-dialysis patients with chronic kidney disease were randomly divided into 3,4-intervention group and control group, intervention group patients with calcium and phosphorus metabolism in early intervention were observed in patients with calcium, phosphorus, and left ventricular mass index changes. Results Patients in the intervention group after the intervention of phosphorus,calcium and phosphorus product,serum parathyroid hormone were significantly lower than the control group,the difference was all statistically significant (all P<0.05 );intervention group of LVMI was significantly lower than before the intervention, but also significantly lower than the control group, the difference was statistically significant (P<0.05). Conclusion Patients with chronic renal calcium and phosphorus metabolism of early intervention can improve symptoms in patients with left ventricular hypertrophy is beneficial to the improvement of patients with the disease.
出处 《中国基层医药》 CAS 2010年第24期3359-3360,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 慢性肾脏病 左室肥厚 钙磷代谢 早期干预 Chronic kidney disease Left ventricular hypertrophy Calcium and phosphorus metabolism Early intervention
  • 相关文献

参考文献10

二级参考文献47

  • 1侯凡凡.慢性肾脏病并发的心血管疾病及其防治[J].实用医院临床杂志,2005,2(1):15-16. 被引量:22
  • 2焦衡忠.氨氯地平对高血压左室肥厚逆转的疗效观察[J].医学临床研究,2004,21(12):1417-1418. 被引量:14
  • 3史浩,陈楠,张文,任红,徐耀文,沈平雁,王伟铭,俞海瑾,李晓,冯晓蓓.简化MDRD公式预测慢性肾病患者肾小球滤过率的应用评价及校正[J].中国实用内科杂志,2006,26(5):665-669. 被引量:89
  • 4张训.血液透析患者血管钙化的防治[J].中国血液净化,2007,6(5):233-235. 被引量:16
  • 5刘红,常明,腾兰波,王志宏,刘焱,赵华,付瑶,王伟.尿毒症患者动脉中膜钙化的病理研究[J].中国全科医学,2007,10(13):1067-1069. 被引量:2
  • 6Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 2004, 15:2208-2218.
  • 7London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease:impact on all-canse and cardiovascular mortality. Nephrol Dial Transplant,2003,18 : 1731-1740.
  • 8Gal-Moscovici A, Sprague SM. Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res ,2007 ,22 ( Suppl 2) : s91-94.
  • 9Parfitt AM. The actions of parathyroid hormone on bone : relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part Ⅳ of Ⅳ parts : The state of the bones in uremic hyperparathyroidiam-the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis. Metabolism, 1976,25 : 1157 -1188.
  • 10Dei Valle E, Negri AL, Aguirre C, Fradingcr E, et al. Prevalence of 25 (OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int,2007,11:315-321.

共引文献30

同被引文献16

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部